Lilly Looks To Take POINT On Emerging Cancer Radiopharmaceutical Space

 
• By Joseph Haas
  
Radioisotope
Lilly moves into radioligand therapy for cancer with buyout of Point • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business